 |
MorphoSys AG
MOR
|
1.02 |
- |
2.43 % |
$ 254 M |
Germany |
 |
AgeX Therapeutics
AGE
|
0.995 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aptorum Group Limited
APM
|
3.81 |
$ 0.88 |
- |
$ 6.47 M |
China |
 |
Aquestive Therapeutics
AQST
|
0.827 |
$ 4.12 |
0.37 % |
$ 441 M |
USA |
 |
I-Mab
IMAB
|
8.96 |
- |
- |
$ 866 M |
China |
 |
Akero Therapeutics
AKRO
|
10.9 |
- |
- |
$ 3.67 B |
USA |
 |
Midatech Pharma plc
MTP
|
2.68 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
AlloVir
ALVR
|
2.84 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 |
- |
- |
$ 40.3 B |
USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
0.612 |
$ 9.7 |
1.09 % |
$ 627 M |
USA |
 |
Biophytis SA
BPTS
|
1.34 |
- |
-13.47 % |
$ 169 M |
France |
 |
Genfit SA
GNFT
|
0.922 |
- |
2.54 % |
$ 160 B |
France |
 |
ACADIA Pharmaceuticals
ACAD
|
2.61 |
$ 21.83 |
-2.76 % |
$ 3.62 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Athira Pharma
ATHA
|
1.43 |
- |
- |
$ 269 M |
USA |
 |
Applied Molecular Transport
AMTI
|
2.31 |
- |
- |
$ 10.1 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
1.75 |
- |
- |
$ 96.9 B |
Britain |
 |
Burford Capital Limited
BUR
|
2.14 |
$ 5.0 |
1.42 % |
$ 801 M |
Britain |
 |
Atreca
BCEL
|
2.02 |
- |
-11.76 % |
$ 5.79 M |
USA |
 |
Berkeley Lights
BLI
|
2.69 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Calithera Biosciences
CALA
|
4.13 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Advaxis
ADXS
|
5.93 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
CymaBay Therapeutics
CBAY
|
3.05 |
- |
- |
$ 3.45 B |
USA |
 |
ChemoCentryx
CCXI
|
3.05 |
- |
- |
$ 3.74 B |
USA |
 |
Cerus Corporation
CERS
|
1.41 |
$ 2.91 |
43.35 % |
$ 555 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 |
- |
- |
- |
Russia |
 |
Caladrius Biosciences
CLBS
|
6.16 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Checkmate Pharmaceuticals
CMPI
|
8.41 |
- |
- |
$ 231 M |
USA |
 |
Aeterna Zentaris
AEZS
|
1.22 |
- |
5.93 % |
$ 314 M |
Canada |
 |
BioNTech SE
BNTX
|
7.95 |
$ 96.45 |
-6.77 % |
$ 27.2 B |
Germany |
 |
Brainstorm Cell Therapeutics
BCLI
|
0.0929 |
- |
-2.5 % |
$ 5.88 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 |
- |
- |
$ 26.5 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.86 |
- |
- |
$ 2.18 B |
USA |
 |
AIkido Pharma
AIKI
|
2.59 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Innate Pharma S.A.
IPHA
|
2.03 |
$ 1.44 |
- |
$ 235 M |
France |
 |
Dynavax Technologies Corporation
DVAX
|
2.53 |
- |
- |
$ 2.02 B |
USA |
 |
Akouos
AKUS
|
6.18 |
- |
0.23 % |
$ 488 M |
USA |
 |
Allakos
ALLK
|
3.26 |
- |
- |
$ 28.6 M |
USA |
 |
Editas Medicine
EDIT
|
1.17 |
$ 2.9 |
-3.33 % |
$ 257 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 |
$ 3.04 |
-4.7 % |
$ 5 M |
Israel |
 |
Eiger BioPharmaceuticals
EIGR
|
0.729 |
- |
-9.21 % |
$ 2.55 M |
USA |
 |
Edesa Biotech
EDSA
|
2.08 |
$ 18.7 |
2.33 % |
$ 59.8 M |
USA |
 |
Eloxx Pharmaceuticals
ELOX
|
0.665 |
- |
-5.68 % |
$ 8.28 M |
USA |
 |
CureVac N.V.
CVAC
|
2.47 |
- |
- |
$ 867 M |
Germany |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Evogene Ltd.
EVGN
|
2.48 |
$ 0.78 |
-0.37 % |
$ 27.9 M |
Israel |
 |
Applied Therapeutics
APLT
|
0.762 |
- |
- |
$ 8.42 M |
USA |
 |
Aptose Biosciences
APTO
|
0.269 |
- |
-45.71 % |
$ 1.2 M |
Canada |